DexCom, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 964.10 M

DexCom, Inc. Operating Cash Flow is USD 964.10 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 20.17% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • DexCom, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 802.30 M, a 6.42% change year over year.
  • DexCom, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 753.90 M, a 55.22% change year over year.
  • DexCom, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 485.70 M, a -3.15% change year over year.
  • DexCom, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 501.50 M, a 64.64% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities